Downregulation of connective tissue growth factor by LPS/IFN-γ-induced nitric oxide is reversed by aristolochic acid treatment in glomerular mesangial cells via STAT-1α and NF-κB signaling

•LPS/IFN-γ-induced NO downregulates CTGF protein expression in MES-13 cells.•AA significantly suppressed LPS/IFN-γ-induced NO production in MES-13 cells.•AA significantly reversed CTGF expression that was downregulated by LPS/IFN-γ.•AA decreased STAT-1α phosphorylation and IRF-1 mRNA expression in M...

Full description

Saved in:
Bibliographic Details
Published inChemico-biological interactions Vol. 210; pp. 86 - 95
Main Authors Tsai, Kuen-daw, Chen, Wei, Wang, Sue-Hong, Hsiao, Yu-Wei, Chi, Jhih-Ying, Wu, Hsing-Yu, Lee, Yi-Ju, Wong, Ho-Yiu, Tseng, Min-Jen, Lin, Ting-Hui
Format Journal Article
LanguageEnglish
Published Ireland Elsevier Ireland Ltd 05.03.2014
Subjects
Online AccessGet full text
ISSN0009-2797
1872-7786
1872-7786
DOI10.1016/j.cbi.2013.12.017

Cover

Abstract •LPS/IFN-γ-induced NO downregulates CTGF protein expression in MES-13 cells.•AA significantly suppressed LPS/IFN-γ-induced NO production in MES-13 cells.•AA significantly reversed CTGF expression that was downregulated by LPS/IFN-γ.•AA decreased STAT-1α phosphorylation and IRF-1 mRNA expression in MES-13 cells.•AA attenuated IKB phosphorylation and reduced NF-κB activation in MES-13 cells. Aristolochic acid (AA) is a common cause of Chinese herb nephropathy. The mechanisms involved in the pathogenesis of AA nephropathy (AAN) are intricate. One well-documented effect of AA in the kidney is its pro-fibrotic activity. Nitric oxide (NO), a messenger gas generated from l-arginine, is the product of nitric oxide synthase (NOS). NO is involved in renal hemodynamics and exerts cytoprotective effects against renal injury. In the present study, the role of NO in AAN was investigated in MES-13 cells, a glomerular mesangial cell line. NO endogenously generated by the induction of inducible nitric oxide synthase (iNOS) with lipopolysaccharide (LPS)/interferon-γ (IFN-γ) significantly downregulated connective tissue growth factor (CTGF) protein expression in MES-13 cells. AA significantly suppressed LPS/IFN-γ-induced NO production and reversed CTGF expression that was downregulated by LPS/IFN-γ. AA decreased iNOS gene and protein expressions in a concentration-dependent manner. AA caused declines in LPS/IFN-γ-induced signal transducer and activator of transcription-1α (STAT-1α) phosphorylation and interferon response factor-1 (IRF-1) mRNA expression. Furthermore, AA attenuated IκB phosphorylation and reduced NF-κB translocation to the nuclear fraction. Taken together, our data indicate that AA reversed the CTGF expression inhibited by LPS/IFN-γ treatment via suppression of NO and iNOS expressions in MES-13 cells through inhibition of the JAK/STAT-1α and NF-κB signaling pathways. NO potentially exerts antifibrotic activity by down regulation of CTGF in MES-13 cells and inhibition of the iNOS gene by AA might partially account for the fibrotic effects of AA in nephropathy.
AbstractList Aristolochic acid (AA) is a common cause of Chinese herb nephropathy. The mechanisms involved in the pathogenesis of AA nephropathy (AAN) are intricate. One well-documented effect of AA in the kidney is its pro-fibrotic activity. Nitric oxide (NO), a messenger gas generated from l-arginine, is the product of nitric oxide synthase (NOS). NO is involved in renal hemodynamics and exerts cytoprotective effects against renal injury. In the present study, the role of NO in AAN was investigated in MES-13 cells, a glomerular mesangial cell line. NO endogenously generated by the induction of inducible nitric oxide synthase (iNOS) with lipopolysaccharide (LPS)/interferon-γ (IFN-γ) significantly downregulated connective tissue growth factor (CTGF) protein expression in MES-13 cells. AA significantly suppressed LPS/IFN-γ-induced NO production and reversed CTGF expression that was downregulated by LPS/IFN-γ. AA decreased iNOS gene and protein expressions in a concentration-dependent manner. AA caused declines in LPS/IFN-γ-induced signal transducer and activator of transcription-1α (STAT-1α) phosphorylation and interferon response factor-1 (IRF-1) mRNA expression. Furthermore, AA attenuated IκB phosphorylation and reduced NF-κB translocation to the nuclear fraction. Taken together, our data indicate that AA reversed the CTGF expression inhibited by LPS/IFN-γ treatment via suppression of NO and iNOS expressions in MES-13 cells through inhibition of the JAK/STAT-1α and NF-κB signaling pathways. NO potentially exerts antifibrotic activity by down regulation of CTGF in MES-13 cells and inhibition of the iNOS gene by AA might partially account for the fibrotic effects of AA in nephropathy.Aristolochic acid (AA) is a common cause of Chinese herb nephropathy. The mechanisms involved in the pathogenesis of AA nephropathy (AAN) are intricate. One well-documented effect of AA in the kidney is its pro-fibrotic activity. Nitric oxide (NO), a messenger gas generated from l-arginine, is the product of nitric oxide synthase (NOS). NO is involved in renal hemodynamics and exerts cytoprotective effects against renal injury. In the present study, the role of NO in AAN was investigated in MES-13 cells, a glomerular mesangial cell line. NO endogenously generated by the induction of inducible nitric oxide synthase (iNOS) with lipopolysaccharide (LPS)/interferon-γ (IFN-γ) significantly downregulated connective tissue growth factor (CTGF) protein expression in MES-13 cells. AA significantly suppressed LPS/IFN-γ-induced NO production and reversed CTGF expression that was downregulated by LPS/IFN-γ. AA decreased iNOS gene and protein expressions in a concentration-dependent manner. AA caused declines in LPS/IFN-γ-induced signal transducer and activator of transcription-1α (STAT-1α) phosphorylation and interferon response factor-1 (IRF-1) mRNA expression. Furthermore, AA attenuated IκB phosphorylation and reduced NF-κB translocation to the nuclear fraction. Taken together, our data indicate that AA reversed the CTGF expression inhibited by LPS/IFN-γ treatment via suppression of NO and iNOS expressions in MES-13 cells through inhibition of the JAK/STAT-1α and NF-κB signaling pathways. NO potentially exerts antifibrotic activity by down regulation of CTGF in MES-13 cells and inhibition of the iNOS gene by AA might partially account for the fibrotic effects of AA in nephropathy.
•LPS/IFN-γ-induced NO downregulates CTGF protein expression in MES-13 cells.•AA significantly suppressed LPS/IFN-γ-induced NO production in MES-13 cells.•AA significantly reversed CTGF expression that was downregulated by LPS/IFN-γ.•AA decreased STAT-1α phosphorylation and IRF-1 mRNA expression in MES-13 cells.•AA attenuated IKB phosphorylation and reduced NF-κB activation in MES-13 cells. Aristolochic acid (AA) is a common cause of Chinese herb nephropathy. The mechanisms involved in the pathogenesis of AA nephropathy (AAN) are intricate. One well-documented effect of AA in the kidney is its pro-fibrotic activity. Nitric oxide (NO), a messenger gas generated from l-arginine, is the product of nitric oxide synthase (NOS). NO is involved in renal hemodynamics and exerts cytoprotective effects against renal injury. In the present study, the role of NO in AAN was investigated in MES-13 cells, a glomerular mesangial cell line. NO endogenously generated by the induction of inducible nitric oxide synthase (iNOS) with lipopolysaccharide (LPS)/interferon-γ (IFN-γ) significantly downregulated connective tissue growth factor (CTGF) protein expression in MES-13 cells. AA significantly suppressed LPS/IFN-γ-induced NO production and reversed CTGF expression that was downregulated by LPS/IFN-γ. AA decreased iNOS gene and protein expressions in a concentration-dependent manner. AA caused declines in LPS/IFN-γ-induced signal transducer and activator of transcription-1α (STAT-1α) phosphorylation and interferon response factor-1 (IRF-1) mRNA expression. Furthermore, AA attenuated IκB phosphorylation and reduced NF-κB translocation to the nuclear fraction. Taken together, our data indicate that AA reversed the CTGF expression inhibited by LPS/IFN-γ treatment via suppression of NO and iNOS expressions in MES-13 cells through inhibition of the JAK/STAT-1α and NF-κB signaling pathways. NO potentially exerts antifibrotic activity by down regulation of CTGF in MES-13 cells and inhibition of the iNOS gene by AA might partially account for the fibrotic effects of AA in nephropathy.
Aristolochic acid (AA) is a common cause of Chinese herb nephropathy. The mechanisms involved in the pathogenesis of AA nephropathy (AAN) are intricate. One well-documented effect of AA in the kidney is its pro-fibrotic activity. Nitric oxide (NO), a messenger gas generated from l-arginine, is the product of nitric oxide synthase (NOS). NO is involved in renal hemodynamics and exerts cytoprotective effects against renal injury. In the present study, the role of NO in AAN was investigated in MES-13 cells, a glomerular mesangial cell line. NO endogenously generated by the induction of inducible nitric oxide synthase (iNOS) with lipopolysaccharide (LPS)/interferon-γ (IFN-γ) significantly downregulated connective tissue growth factor (CTGF) protein expression in MES-13 cells. AA significantly suppressed LPS/IFN-γ-induced NO production and reversed CTGF expression that was downregulated by LPS/IFN-γ. AA decreased iNOS gene and protein expressions in a concentration-dependent manner. AA caused declines in LPS/IFN-γ-induced signal transducer and activator of transcription-1α (STAT-1α) phosphorylation and interferon response factor-1 (IRF-1) mRNA expression. Furthermore, AA attenuated IκB phosphorylation and reduced NF-κB translocation to the nuclear fraction. Taken together, our data indicate that AA reversed the CTGF expression inhibited by LPS/IFN-γ treatment via suppression of NO and iNOS expressions in MES-13 cells through inhibition of the JAK/STAT-1α and NF-κB signaling pathways. NO potentially exerts antifibrotic activity by down regulation of CTGF in MES-13 cells and inhibition of the iNOS gene by AA might partially account for the fibrotic effects of AA in nephropathy.
Author Tsai, Kuen-daw
Chen, Wei
Tseng, Min-Jen
Wu, Hsing-Yu
Wang, Sue-Hong
Chi, Jhih-Ying
Wong, Ho-Yiu
Lin, Ting-Hui
Hsiao, Yu-Wei
Lee, Yi-Ju
Author_xml – sequence: 1
  givenname: Kuen-daw
  surname: Tsai
  fullname: Tsai, Kuen-daw
  organization: Department of Internal Medicine, China Medical University and Beigang Hospital, 123, Sinde Road, Beigang Township, Yunlin County 65152, Taiwan, ROC
– sequence: 2
  givenname: Wei
  surname: Chen
  fullname: Chen, Wei
  organization: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chia-Yi Christian Hospital, Chiayi, Taiwan, ROC
– sequence: 3
  givenname: Sue-Hong
  surname: Wang
  fullname: Wang, Sue-Hong
  organization: Department of Biomedical Sciences, Chung Shan Medical University, No. 110, Jianguo North Road, Section 1, Taichung 40203, Taiwan, ROC
– sequence: 4
  givenname: Yu-Wei
  surname: Hsiao
  fullname: Hsiao, Yu-Wei
  organization: Department of Biomedical Sciences, Chung Shan Medical University, No. 110, Jianguo North Road, Section 1, Taichung 40203, Taiwan, ROC
– sequence: 5
  givenname: Jhih-Ying
  surname: Chi
  fullname: Chi, Jhih-Ying
  organization: Department of Biomedical Sciences, Chung Shan Medical University, No. 110, Jianguo North Road, Section 1, Taichung 40203, Taiwan, ROC
– sequence: 6
  givenname: Hsing-Yu
  surname: Wu
  fullname: Wu, Hsing-Yu
  organization: Department of Biomedical Sciences, Chung Shan Medical University, No. 110, Jianguo North Road, Section 1, Taichung 40203, Taiwan, ROC
– sequence: 7
  givenname: Yi-Ju
  surname: Lee
  fullname: Lee, Yi-Ju
  organization: Institute of Microbiology and Immunology, Chung Shan Medical University, No. 110, Jianguo North Road, Section 1, Taichung 40203, Taiwan, ROC
– sequence: 8
  givenname: Ho-Yiu
  surname: Wong
  fullname: Wong, Ho-Yiu
  organization: Department of Internal Medicine, China Medical University and Beigang Hospital, 123, Sinde Road, Beigang Township, Yunlin County 65152, Taiwan, ROC
– sequence: 9
  givenname: Min-Jen
  surname: Tseng
  fullname: Tseng, Min-Jen
  organization: Institute of Molecular Biology, National Chung Cheng University, 168 University Road, Minhsiung Township, Chiayi County 62102, Taiwan, ROC
– sequence: 10
  givenname: Ting-Hui
  surname: Lin
  fullname: Lin, Ting-Hui
  email: thlin@csmu.edu.tw, yylin2332@gmail.com
  organization: Department of Biomedical Sciences, Chung Shan Medical University, No. 110, Jianguo North Road, Section 1, Taichung 40203, Taiwan, ROC
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24412304$$D View this record in MEDLINE/PubMed
BookMark eNp9kUFu1DAUQCNURKeFA7BBXrLJ1HaccSJWpTBQaVSQOqwtx_lJ_yixi-1M6bEQOzbcYM6EhyksWHRlWX7P-vrvJDuyzkKWvWR0zihbnG3mpsE5p6yYMz6nTD7JZqySPJeyWhxlM0ppnXNZy-PsJIRNulIu6LPsmAvBeEHFLPv1zt1ZD_006IjOEtcR46wFE3ELJGIIE5Deu7t4QzptovOkuSerz9dnl8urfPcjR9tOBlpiMXo0xH3DFggG4mELPqSHhGuPIbrBmZtEaIMtiR50HMFGgpb0gxvBpwk8GSFo26MeiIFhCGSLmlyvz9c5230n2rbkapnvfr4lAXurB7T98-xpp4cALx7O0-zL8v364mO--vTh8uJ8lRu-qGIOxrCu6RrOBK-FqKqClV1ZaSMbWHDQpRAd6yRlbaG1rkpqqCmhFrysqk42tDjNXh_-vfXu6wQhqhHDfkZtwU1BMVHXTLBSlgl99YBOzQituvU4an-v_i49AewAGO9C8ND9QxhV-7Bqo1JYtQ-rGFcpbHLkf47B-CdZ9BqHR803BxPSerYIXgWDYFMz9Cmzah0-Yv8GxxTBwg
CitedBy_id crossref_primary_10_15407_ubj93_06_005
crossref_primary_10_3389_fphar_2020_569551
crossref_primary_10_3389_fcell_2021_809952
crossref_primary_10_1016_j_cbi_2016_06_029
crossref_primary_10_1007_s12079_020_00602_2
crossref_primary_10_1016_j_redox_2016_09_014
crossref_primary_10_1016_j_theriogenology_2018_03_038
crossref_primary_10_3389_fimmu_2017_00610
crossref_primary_10_3892_etm_2017_4297
crossref_primary_10_1155_2021_8877056
crossref_primary_10_1113_EP085333
Cites_doi 10.1111/j.1524-475X.2007.00308.x
10.1111/j.1365-2362.2008.01941.x
10.1084/jem.177.6.1779
10.1080/10799890903078465
10.1093/nar/22.15.3033
10.1016/j.lfs.2003.10.042
10.1146/annurev.bi.64.070195.003201
10.1016/0162-3109(93)90061-T
10.1016/j.toxicon.2007.03.011
10.1016/0140-6736(93)92984-2
10.1111/j.1523-1755.1998.00820.x
10.1093/ndt/gfm667
10.1111/j.1523-1755.2004.00905.x
10.1093/ndt/16.suppl_1.60
10.1046/j.1523-1755.2002.00462.x
10.1002/path.2769
10.1006/niox.2001.0410
10.1016/j.matbio.2011.07.004
10.1093/carcin/bgm082
10.1152/ajprenal.00424.2007
10.1038/aps.2009.197
10.1016/0005-2760(89)90299-3
10.1016/j.ejphar.2004.07.030
10.1016/j.cbi.2011.03.012
10.1038/labinvest.3780182
10.1006/niox.2001.0421
10.1002/biof.30
10.1681/ASN.V7102202
10.1016/j.taap.2012.03.011
10.1097/00002281-200211000-00009
10.1515/BC.2007.056
10.1038/ni1001-907
10.1016/S0272-6386(97)90275-4
10.1146/annurev.immunol.021908.132641
10.1006/abio.1995.1079
10.1007/s004670200004
10.1681/ASN.2008060653
10.1016/j.niox.2007.10.005
10.1016/S0272-6386(00)70343-X
ContentType Journal Article
Copyright 2014 Elsevier Ireland Ltd
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Copyright_xml – notice: 2014 Elsevier Ireland Ltd
– notice: Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.cbi.2013.12.017
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
Biology
EISSN 1872-7786
EndPage 95
ExternalDocumentID 24412304
10_1016_j_cbi_2013_12_017
S0009279714000088
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
-~X
.~1
0R~
1B1
1RT
1~.
1~5
29B
4.4
457
4G.
5GY
5RE
5VS
6J9
7-5
71M
8P~
9JM
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AAOAW
AAQFI
AATCM
AAXUO
ABFRF
ABFYP
ABJNI
ABLST
ABMAC
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
AEBSH
AEFWE
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHEUO
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AKIFW
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
AXJTR
BKOJK
BLECG
BLXMC
CS3
DU5
EBS
EFJIC
EFLBG
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
IHE
J1W
KCYFY
KOM
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OZT
P-8
P-9
P2P
PC.
Q38
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SPCBC
SSJ
SSP
SSZ
T5K
WH7
~G-
.GJ
3O-
53G
AALRI
AAQXK
AATTM
AAXKI
AAYJJ
AAYWO
AAYXX
ABEFU
ABFNM
ABWVN
ACRPL
ACVFH
ADCNI
ADMUD
ADNMO
ADVLN
AEIPS
AEUPX
AFFNX
AFJKZ
AFPUW
AGCQF
AGQPQ
AHHHB
AI.
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
ASPBG
AVWKF
AZFZN
CITATION
EFKBS
EJD
FEDTE
FGOYB
G-2
HMT
HVGLF
HZ~
H~9
R2-
SEW
SPT
VH1
WUQ
ZGI
ZXP
~HD
CGR
CUY
CVF
ECM
EIF
NPM
SSH
7X8
ID FETCH-LOGICAL-c268t-ecc1fbfb214294488315f58ac7be62ea544f1f701d3aaa850c0c5e942588f7b03
IEDL.DBID AIKHN
ISSN 0009-2797
1872-7786
IngestDate Fri Sep 05 06:31:33 EDT 2025
Thu Apr 03 06:59:49 EDT 2025
Thu Apr 24 22:54:56 EDT 2025
Thu Sep 18 00:11:58 EDT 2025
Fri Feb 23 02:31:33 EST 2024
IsPeerReviewed true
IsScholarly true
Keywords NO
Glomerular mesangial cells
TGF β
CHN
IRF-1
Aristolochic acid
MTT
LPS
STAT-1α
CTGF
IκB
NF-κB
IFN-γ
γ-IRE
EMSA
iNOS
TNF α
CKD
AA
TBS
PDEs
IKK
PLA2
TBST
Connective tissue growth factor
CM
Q-RT-PCR
IL-1β
MAPK
AAN
ECM
JAK
Nitric oxide
GAS
MES-13 cells
PVDF membrane
GAPDH
TLR4
Language English
License Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c268t-ecc1fbfb214294488315f58ac7be62ea544f1f701d3aaa850c0c5e942588f7b03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 24412304
PQID 1499141575
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_1499141575
pubmed_primary_24412304
crossref_primary_10_1016_j_cbi_2013_12_017
crossref_citationtrail_10_1016_j_cbi_2013_12_017
elsevier_sciencedirect_doi_10_1016_j_cbi_2013_12_017
PublicationCentury 2000
PublicationDate 2014-03-05
PublicationDateYYYYMMDD 2014-03-05
PublicationDate_xml – month: 03
  year: 2014
  text: 2014-03-05
  day: 05
PublicationDecade 2010
PublicationPlace Ireland
PublicationPlace_xml – name: Ireland
PublicationTitle Chemico-biological interactions
PublicationTitleAlternate Chem Biol Interact
PublicationYear 2014
Publisher Elsevier Ireland Ltd
Publisher_xml – name: Elsevier Ireland Ltd
References de Jonge, Vanrenterghem (b0025) 2008; 23
Kikuchi, Katsuramaki, Kukita, Taketani, Meguro, Nagayama, Isobe, Mizuguchi, Hirata (b0120) 2007; 15
Morrissey, Ishidoya, McCracken, Klahr (b0130) 1996; 7
Ito, Aten, Bende, Oemar, Rabelink, Weening, Goldschmeding (b0055) 1998; 53
Baylis (b0065) 2008; 294
Debelle, Nortier, Husson, De Prez, Vienne, Rombaut, Salmon, Deschodt-Lanckman, Vanherweghem (b0105) 2004; 66
Chen, Chiang, Wu, Kao, Hsiang, Ho, Lin (b0170) 2010; 31
Wu, Chou, Cheng, Hsiao, Wang, Wang, Sheu, Hsiao (b0175) 2011; 192
Hochberg, Johnson, Chen, Cohen, Stern, Vaughan, Poppas, Felsen (b0135) 2000; 80
Schindler, Darnell (b0080) 1995; 64
Rein, Muller, Zorbas (b0090) 1994; 22
Trachtman, Futterweit, Pine, Mann, Valderrama (b0140) 2002; 17
Moreno (b0190) 1993; 26
Vallabhapurapu, Karin (b0165) 2009; 27
Fragiadaki, Witherden, Kaneko, Sonnylal, Pusey, Bou-Gharios, Mason (b0060) 2011; 30
Verdon, Burton, Prior (b0075) 1995; 224
Ihn (b0050) 2002; 14
Ferrini, Vernet, Magee, Shahed, Qian, Rajfer, Gonzalez-Cadavid (b0125) 2002; 6
Kleinert, Pautz, Linker, Schwarz (b0095) 2004; 500
Lukivskaya, Patsenker, Lis, Buko (b0110) 2008; 38
Yang, Lin, Chang, Hsu (b0040) 2000; 35
Forstermann, Sessa (b0015) 2012; 33
Vivancos, Moreno (b0180) 2002; 6
Aktan (b0010) 2004; 75
Sims, Cha, Romine, Gao, Gottlieb, Deisseroth (b0160) 1993; 13
Kone (b0020) 1997; 30
Li, Zhang, Wang, Wang, Li, Wu (b0100) 2009; 29
Dreieicher, Beck, Lazaroski, Boosen, Tsalastra-Greul, Beck, Fleming, Schaefer, Pfeilschifter (b0145) 2009; 20
Cicha, Goppelt-Struebe (b0045) 2009; 35
Xie, Whisnant, Nathan (b0085) 1993; 177
Chen, Fan, Tseng, Ho, Hsu (b0205) 2007; 50
Lin, Hsieh, Lee, Liu, Lin (b0195) 2008; 18
Vanherweghem, Depierreux, Tielemans, Abramowicz, Dratwa, Jadoul, Richard, Vandervelde, Verbeelen, Vanhaelen-Fastre (b0035) 1993; 341
Rosenthal, Vishwanath, Franson (b0185) 1989; 1001
Klahr (b0070) 2001; 16
Wani, Carl, Henger, Nelson, Rupprecht (b0155) 2007; 388
Mihout, Shweke, Bige, Jouanneau, Dussaule, Ronco, Chatziantoniou, Boffa (b0115) 2011; 223
Keil, Blom, Goldschmeding, Rupprecht (b0150) 2002; 62
Ding, Chen (b0200) 2012; 261
Bogdan (b0005) 2001; 2
Arlt, Stiborova, vom Brocke, Simoes, Lord, Nortier, Hollstein, Phillips, Schmeiser (b0030) 2007; 28
Kone (10.1016/j.cbi.2013.12.017_b0020) 1997; 30
Schindler (10.1016/j.cbi.2013.12.017_b0080) 1995; 64
Kleinert (10.1016/j.cbi.2013.12.017_b0095) 2004; 500
Forstermann (10.1016/j.cbi.2013.12.017_b0015) 2012; 33
Kikuchi (10.1016/j.cbi.2013.12.017_b0120) 2007; 15
Aktan (10.1016/j.cbi.2013.12.017_b0010) 2004; 75
Vivancos (10.1016/j.cbi.2013.12.017_b0180) 2002; 6
de Jonge (10.1016/j.cbi.2013.12.017_b0025) 2008; 23
Klahr (10.1016/j.cbi.2013.12.017_b0070) 2001; 16
Vallabhapurapu (10.1016/j.cbi.2013.12.017_b0165) 2009; 27
Ferrini (10.1016/j.cbi.2013.12.017_b0125) 2002; 6
Rosenthal (10.1016/j.cbi.2013.12.017_b0185) 1989; 1001
Arlt (10.1016/j.cbi.2013.12.017_b0030) 2007; 28
Moreno (10.1016/j.cbi.2013.12.017_b0190) 1993; 26
Fragiadaki (10.1016/j.cbi.2013.12.017_b0060) 2011; 30
Keil (10.1016/j.cbi.2013.12.017_b0150) 2002; 62
Ihn (10.1016/j.cbi.2013.12.017_b0050) 2002; 14
Bogdan (10.1016/j.cbi.2013.12.017_b0005) 2001; 2
Wani (10.1016/j.cbi.2013.12.017_b0155) 2007; 388
Xie (10.1016/j.cbi.2013.12.017_b0085) 1993; 177
Lukivskaya (10.1016/j.cbi.2013.12.017_b0110) 2008; 38
Yang (10.1016/j.cbi.2013.12.017_b0040) 2000; 35
Cicha (10.1016/j.cbi.2013.12.017_b0045) 2009; 35
Dreieicher (10.1016/j.cbi.2013.12.017_b0145) 2009; 20
Morrissey (10.1016/j.cbi.2013.12.017_b0130) 1996; 7
Trachtman (10.1016/j.cbi.2013.12.017_b0140) 2002; 17
Wu (10.1016/j.cbi.2013.12.017_b0175) 2011; 192
Debelle (10.1016/j.cbi.2013.12.017_b0105) 2004; 66
Ito (10.1016/j.cbi.2013.12.017_b0055) 1998; 53
Chen (10.1016/j.cbi.2013.12.017_b0205) 2007; 50
Ding (10.1016/j.cbi.2013.12.017_b0200) 2012; 261
Li (10.1016/j.cbi.2013.12.017_b0100) 2009; 29
Chen (10.1016/j.cbi.2013.12.017_b0170) 2010; 31
Lin (10.1016/j.cbi.2013.12.017_b0195) 2008; 18
Rein (10.1016/j.cbi.2013.12.017_b0090) 1994; 22
Verdon (10.1016/j.cbi.2013.12.017_b0075) 1995; 224
Hochberg (10.1016/j.cbi.2013.12.017_b0135) 2000; 80
Baylis (10.1016/j.cbi.2013.12.017_b0065) 2008; 294
Mihout (10.1016/j.cbi.2013.12.017_b0115) 2011; 223
Vanherweghem (10.1016/j.cbi.2013.12.017_b0035) 1993; 341
Sims (10.1016/j.cbi.2013.12.017_b0160) 1993; 13
References_xml – volume: 18
  start-page: 93
  year: 2008
  end-page: 104
  ident: b0195
  article-title: AH23848 accelerates inducible nitric oxide synthase degradation through attenuation of cAMP signaling in glomerular mesangial cells
  publication-title: Nitric Oxide
– volume: 30
  start-page: 311
  year: 1997
  end-page: 333
  ident: b0020
  article-title: Nitric oxide in renal health and disease
  publication-title: Am. J. Kidney Dis.
– volume: 294
  start-page: F1
  year: 2008
  end-page: 9
  ident: b0065
  article-title: Nitric oxide deficiency in chronic kidney disease
  publication-title: Am. J. Physiol. Renal Physiol.
– volume: 15
  start-page: 881
  year: 2007
  end-page: 888
  ident: b0120
  article-title: New strategy for the antifibrotic therapy with oral administration of FR260330 (a selective inducible nitric oxide synthase inhibitor) in rat experimental liver cirrhosis
  publication-title: Wound Repair Regen.
– volume: 6
  start-page: 283
  year: 2002
  end-page: 294
  ident: b0125
  article-title: Antifibrotic role of inducible nitric oxide synthase
  publication-title: Nitric Oxide
– volume: 28
  start-page: 2253
  year: 2007
  end-page: 2261
  ident: b0030
  article-title: Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer
  publication-title: Carcinogenesis
– volume: 261
  start-page: 59
  year: 2012
  end-page: 65
  ident: b0200
  article-title: Developmental nephrotoxicity of aristolochic acid in a zebrafish model
  publication-title: Toxicol. Appl. Pharmacol.
– volume: 26
  start-page: 1
  year: 1993
  end-page: 9
  ident: b0190
  article-title: Effect of aristolochic acid on arachidonic acid cascade and in vivo models of inflammation
  publication-title: Immunopharmacology
– volume: 33
  year: 2012
  ident: b0015
  article-title: Nitric oxide synthases: regulation and function
  publication-title: Eur. Heart J.
– volume: 29
  start-page: 280
  year: 2009
  end-page: 285
  ident: b0100
  article-title: TGF-beta 1/Smads signaling stimulates renal interstitial fibrosis in experimental AAN
  publication-title: J. Recept. Signal Transduct. Res.
– volume: 6
  start-page: 255
  year: 2002
  end-page: 262
  ident: b0180
  article-title: Role of Ca(2+)-independent phospholipase A(2) and cyclooxygenase/lipoxygenase pathways in the nitric oxide production by murine macrophages stimulated by lipopolysaccharides
  publication-title: Nitric oxide
– volume: 192
  start-page: 209
  year: 2011
  end-page: 219
  ident: b0175
  article-title: Aristolochic acid downregulates monocytic matrix metalloproteinase-9 by inhibiting nuclear factor-kappaB activation
  publication-title: Chem. Biol. Interact.
– volume: 27
  start-page: 693
  year: 2009
  end-page: 733
  ident: b0165
  article-title: Regulation and function of NF-kappaB transcription factors in the immune system
  publication-title: Annu. Rev. Immunol.
– volume: 38
  start-page: 317
  year: 2008
  end-page: 325
  ident: b0110
  article-title: Inhibition of inducible nitric oxide synthase activity prevents liver recovery in rat thioacetamide-induced fibrosis reversal
  publication-title: Eur. J. Clin. Invest.
– volume: 22
  start-page: 3033
  year: 1994
  end-page: 3037
  ident: b0090
  article-title: In vivo footprinting of the IRF-1 promoter: inducible occupation of a GAS element next to a persistent structural alteration of the DNA
  publication-title: Nucleic Acids Res.
– volume: 2
  start-page: 907
  year: 2001
  end-page: 916
  ident: b0005
  article-title: Nitric oxide and the immune response
  publication-title: Nat. Immunol.
– volume: 35
  start-page: 313
  year: 2000
  end-page: 318
  ident: b0040
  article-title: Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs
  publication-title: Am. J. Kidney Dis.
– volume: 13
  start-page: 690
  year: 1993
  end-page: 702
  ident: b0160
  article-title: A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter
  publication-title: Mol. Cell. Biol.
– volume: 66
  start-page: 1815
  year: 2004
  end-page: 1825
  ident: b0105
  article-title: The renin-angiotensin system blockade does not prevent renal interstitial fibrosis induced by aristolochic acids
  publication-title: Kidney Int.
– volume: 17
  start-page: 20
  year: 2002
  end-page: 29
  ident: b0140
  article-title: Chronic diabetic nephropathy: role of inducible nitric oxide synthase
  publication-title: Pediatr. Nephrol.
– volume: 64
  start-page: 621
  year: 1995
  end-page: 651
  ident: b0080
  article-title: Transcriptional responses to polypeptide ligands: the JAK-STAT pathway
  publication-title: Annu. Rev. Biochem.
– volume: 224
  start-page: 502
  year: 1995
  end-page: 508
  ident: b0075
  article-title: Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite
  publication-title: Anal. Biochem.
– volume: 62
  start-page: 401
  year: 2002
  end-page: 411
  ident: b0150
  article-title: Nitric oxide down-regulates connective tissue growth factor in rat mesangial cells
  publication-title: Kidney Int.
– volume: 1001
  start-page: 1
  year: 1989
  end-page: 8
  ident: b0185
  article-title: Effects of aristolochic acid on phospholipase A2 activity and arachidonate metabolism of human neutrophils
  publication-title: Biochim. Biophys. Acta
– volume: 16
  start-page: 60
  year: 2001
  end-page: 62
  ident: b0070
  article-title: The role of nitric oxide in hypertension and renal disease progression
  publication-title: Nephrol. Dial. Transplant.
– volume: 23
  start-page: 39
  year: 2008
  end-page: 41
  ident: b0025
  article-title: Aristolochic acid: the common culprit of Chinese herbs nephropathy and Balkan endemic nephropathy
  publication-title: Nephrol. Dial. Transplant.
– volume: 30
  start-page: 396
  year: 2011
  end-page: 403
  ident: b0060
  article-title: Interstitial fibrosis is associated with increased COL1A2 transcription in AA-injured renal tubular epithelial cells
  publication-title: Matrix Biol.
– volume: 50
  start-page: 180
  year: 2007
  end-page: 188
  ident: b0205
  article-title: Pharmacokinetics and nephrotoxicity of aristolochic acid in rabbits
  publication-title: Toxicon
– volume: 14
  start-page: 681
  year: 2002
  end-page: 685
  ident: b0050
  article-title: Pathogenesis of fibrosis: role of TGF-beta and CTGF
  publication-title: Curr. Opin. Rheumatol.
– volume: 75
  start-page: 639
  year: 2004
  end-page: 653
  ident: b0010
  article-title: INOS-mediated nitric oxide production and its regulation
  publication-title: Life Sci.
– volume: 35
  start-page: 200
  year: 2009
  end-page: 208
  ident: b0045
  article-title: Connective tissue growth factor: context-dependent functions and mechanisms of regulation
  publication-title: Biofactors
– volume: 388
  start-page: 497
  year: 2007
  end-page: 506
  ident: b0155
  article-title: Nitric oxide modulates expression of extracellular matrix genes linked to fibrosis in kidney mesangial cells
  publication-title: Biol. Chem.
– volume: 31
  start-page: 227
  year: 2010
  end-page: 236
  ident: b0170
  article-title: Microarray analysis reveals the inhibition of nuclear factor-kappa B signaling by aristolochic acid in normal human kidney (HK-2) cells
  publication-title: Acta Pharmacol. Sin.
– volume: 341
  start-page: 387
  year: 1993
  end-page: 391
  ident: b0035
  article-title: Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs
  publication-title: Lancet
– volume: 7
  start-page: 2202
  year: 1996
  end-page: 2212
  ident: b0130
  article-title: Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy
  publication-title: J. Am. Soc. Nephrol.
– volume: 177
  start-page: 1779
  year: 1993
  end-page: 1784
  ident: b0085
  article-title: Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide
  publication-title: J. Exp. Med.
– volume: 20
  start-page: 1963
  year: 2009
  end-page: 1974
  ident: b0145
  article-title: Nitric oxide inhibits glomerular TGF-beta signaling via SMOC-1
  publication-title: J. Am. Soc. Nephrol.
– volume: 53
  start-page: 853
  year: 1998
  end-page: 861
  ident: b0055
  article-title: Expression of connective tissue growth factor in human renal fibrosis
  publication-title: Kidney Int.
– volume: 80
  start-page: 1721
  year: 2000
  end-page: 1728
  ident: b0135
  article-title: Interstitial fibrosis of unilateral ureteral obstruction is exacerbated in kidneys of mice lacking the gene for inducible nitric oxide synthase
  publication-title: Lab. Invest.
– volume: 500
  start-page: 255
  year: 2004
  end-page: 266
  ident: b0095
  article-title: Regulation of the expression of inducible nitric oxide synthase
  publication-title: Eur. J. Pharmacol.
– volume: 223
  start-page: 37
  year: 2011
  end-page: 45
  ident: b0115
  article-title: Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-beta1 synthesis
  publication-title: J. Pathol.
– volume: 15
  start-page: 881
  year: 2007
  ident: 10.1016/j.cbi.2013.12.017_b0120
  article-title: New strategy for the antifibrotic therapy with oral administration of FR260330 (a selective inducible nitric oxide synthase inhibitor) in rat experimental liver cirrhosis
  publication-title: Wound Repair Regen.
  doi: 10.1111/j.1524-475X.2007.00308.x
– volume: 38
  start-page: 317
  year: 2008
  ident: 10.1016/j.cbi.2013.12.017_b0110
  article-title: Inhibition of inducible nitric oxide synthase activity prevents liver recovery in rat thioacetamide-induced fibrosis reversal
  publication-title: Eur. J. Clin. Invest.
  doi: 10.1111/j.1365-2362.2008.01941.x
– volume: 177
  start-page: 1779
  year: 1993
  ident: 10.1016/j.cbi.2013.12.017_b0085
  article-title: Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.177.6.1779
– volume: 29
  start-page: 280
  year: 2009
  ident: 10.1016/j.cbi.2013.12.017_b0100
  article-title: TGF-beta 1/Smads signaling stimulates renal interstitial fibrosis in experimental AAN
  publication-title: J. Recept. Signal Transduct. Res.
  doi: 10.1080/10799890903078465
– volume: 13
  start-page: 690
  year: 1993
  ident: 10.1016/j.cbi.2013.12.017_b0160
  article-title: A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter
  publication-title: Mol. Cell. Biol.
– volume: 22
  start-page: 3033
  year: 1994
  ident: 10.1016/j.cbi.2013.12.017_b0090
  article-title: In vivo footprinting of the IRF-1 promoter: inducible occupation of a GAS element next to a persistent structural alteration of the DNA
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/22.15.3033
– volume: 75
  start-page: 639
  year: 2004
  ident: 10.1016/j.cbi.2013.12.017_b0010
  article-title: INOS-mediated nitric oxide production and its regulation
  publication-title: Life Sci.
  doi: 10.1016/j.lfs.2003.10.042
– volume: 64
  start-page: 621
  year: 1995
  ident: 10.1016/j.cbi.2013.12.017_b0080
  article-title: Transcriptional responses to polypeptide ligands: the JAK-STAT pathway
  publication-title: Annu. Rev. Biochem.
  doi: 10.1146/annurev.bi.64.070195.003201
– volume: 26
  start-page: 1
  year: 1993
  ident: 10.1016/j.cbi.2013.12.017_b0190
  article-title: Effect of aristolochic acid on arachidonic acid cascade and in vivo models of inflammation
  publication-title: Immunopharmacology
  doi: 10.1016/0162-3109(93)90061-T
– volume: 50
  start-page: 180
  year: 2007
  ident: 10.1016/j.cbi.2013.12.017_b0205
  article-title: Pharmacokinetics and nephrotoxicity of aristolochic acid in rabbits
  publication-title: Toxicon
  doi: 10.1016/j.toxicon.2007.03.011
– volume: 341
  start-page: 387
  year: 1993
  ident: 10.1016/j.cbi.2013.12.017_b0035
  article-title: Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs
  publication-title: Lancet
  doi: 10.1016/0140-6736(93)92984-2
– volume: 53
  start-page: 853
  year: 1998
  ident: 10.1016/j.cbi.2013.12.017_b0055
  article-title: Expression of connective tissue growth factor in human renal fibrosis
  publication-title: Kidney Int.
  doi: 10.1111/j.1523-1755.1998.00820.x
– volume: 23
  start-page: 39
  year: 2008
  ident: 10.1016/j.cbi.2013.12.017_b0025
  article-title: Aristolochic acid: the common culprit of Chinese herbs nephropathy and Balkan endemic nephropathy
  publication-title: Nephrol. Dial. Transplant.
  doi: 10.1093/ndt/gfm667
– volume: 66
  start-page: 1815
  year: 2004
  ident: 10.1016/j.cbi.2013.12.017_b0105
  article-title: The renin-angiotensin system blockade does not prevent renal interstitial fibrosis induced by aristolochic acids
  publication-title: Kidney Int.
  doi: 10.1111/j.1523-1755.2004.00905.x
– volume: 16
  start-page: 60
  issue: Suppl. 1
  year: 2001
  ident: 10.1016/j.cbi.2013.12.017_b0070
  article-title: The role of nitric oxide in hypertension and renal disease progression
  publication-title: Nephrol. Dial. Transplant.
  doi: 10.1093/ndt/16.suppl_1.60
– volume: 62
  start-page: 401
  year: 2002
  ident: 10.1016/j.cbi.2013.12.017_b0150
  article-title: Nitric oxide down-regulates connective tissue growth factor in rat mesangial cells
  publication-title: Kidney Int.
  doi: 10.1046/j.1523-1755.2002.00462.x
– volume: 223
  start-page: 37
  year: 2011
  ident: 10.1016/j.cbi.2013.12.017_b0115
  article-title: Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-beta1 synthesis
  publication-title: J. Pathol.
  doi: 10.1002/path.2769
– volume: 6
  start-page: 255
  year: 2002
  ident: 10.1016/j.cbi.2013.12.017_b0180
  article-title: Role of Ca(2+)-independent phospholipase A(2) and cyclooxygenase/lipoxygenase pathways in the nitric oxide production by murine macrophages stimulated by lipopolysaccharides
  publication-title: Nitric oxide
  doi: 10.1006/niox.2001.0410
– volume: 30
  start-page: 396
  year: 2011
  ident: 10.1016/j.cbi.2013.12.017_b0060
  article-title: Interstitial fibrosis is associated with increased COL1A2 transcription in AA-injured renal tubular epithelial cells in vivo
  publication-title: Matrix Biol.
  doi: 10.1016/j.matbio.2011.07.004
– volume: 28
  start-page: 2253
  year: 2007
  ident: 10.1016/j.cbi.2013.12.017_b0030
  article-title: Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgm082
– volume: 294
  start-page: F1
  year: 2008
  ident: 10.1016/j.cbi.2013.12.017_b0065
  article-title: Nitric oxide deficiency in chronic kidney disease
  publication-title: Am. J. Physiol. Renal Physiol.
  doi: 10.1152/ajprenal.00424.2007
– volume: 31
  start-page: 227
  year: 2010
  ident: 10.1016/j.cbi.2013.12.017_b0170
  article-title: Microarray analysis reveals the inhibition of nuclear factor-kappa B signaling by aristolochic acid in normal human kidney (HK-2) cells
  publication-title: Acta Pharmacol. Sin.
  doi: 10.1038/aps.2009.197
– volume: 1001
  start-page: 1
  year: 1989
  ident: 10.1016/j.cbi.2013.12.017_b0185
  article-title: Effects of aristolochic acid on phospholipase A2 activity and arachidonate metabolism of human neutrophils
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/0005-2760(89)90299-3
– volume: 500
  start-page: 255
  year: 2004
  ident: 10.1016/j.cbi.2013.12.017_b0095
  article-title: Regulation of the expression of inducible nitric oxide synthase
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/j.ejphar.2004.07.030
– volume: 192
  start-page: 209
  year: 2011
  ident: 10.1016/j.cbi.2013.12.017_b0175
  article-title: Aristolochic acid downregulates monocytic matrix metalloproteinase-9 by inhibiting nuclear factor-kappaB activation
  publication-title: Chem. Biol. Interact.
  doi: 10.1016/j.cbi.2011.03.012
– volume: 80
  start-page: 1721
  year: 2000
  ident: 10.1016/j.cbi.2013.12.017_b0135
  article-title: Interstitial fibrosis of unilateral ureteral obstruction is exacerbated in kidneys of mice lacking the gene for inducible nitric oxide synthase
  publication-title: Lab. Invest.
  doi: 10.1038/labinvest.3780182
– volume: 6
  start-page: 283
  year: 2002
  ident: 10.1016/j.cbi.2013.12.017_b0125
  article-title: Antifibrotic role of inducible nitric oxide synthase
  publication-title: Nitric Oxide
  doi: 10.1006/niox.2001.0421
– volume: 35
  start-page: 200
  year: 2009
  ident: 10.1016/j.cbi.2013.12.017_b0045
  article-title: Connective tissue growth factor: context-dependent functions and mechanisms of regulation
  publication-title: Biofactors
  doi: 10.1002/biof.30
– volume: 7
  start-page: 2202
  year: 1996
  ident: 10.1016/j.cbi.2013.12.017_b0130
  article-title: Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy
  publication-title: J. Am. Soc. Nephrol.
  doi: 10.1681/ASN.V7102202
– volume: 261
  start-page: 59
  year: 2012
  ident: 10.1016/j.cbi.2013.12.017_b0200
  article-title: Developmental nephrotoxicity of aristolochic acid in a zebrafish model
  publication-title: Toxicol. Appl. Pharmacol.
  doi: 10.1016/j.taap.2012.03.011
– volume: 14
  start-page: 681
  year: 2002
  ident: 10.1016/j.cbi.2013.12.017_b0050
  article-title: Pathogenesis of fibrosis: role of TGF-beta and CTGF
  publication-title: Curr. Opin. Rheumatol.
  doi: 10.1097/00002281-200211000-00009
– volume: 388
  start-page: 497
  year: 2007
  ident: 10.1016/j.cbi.2013.12.017_b0155
  article-title: Nitric oxide modulates expression of extracellular matrix genes linked to fibrosis in kidney mesangial cells
  publication-title: Biol. Chem.
  doi: 10.1515/BC.2007.056
– volume: 2
  start-page: 907
  year: 2001
  ident: 10.1016/j.cbi.2013.12.017_b0005
  article-title: Nitric oxide and the immune response
  publication-title: Nat. Immunol.
  doi: 10.1038/ni1001-907
– volume: 30
  start-page: 311
  year: 1997
  ident: 10.1016/j.cbi.2013.12.017_b0020
  article-title: Nitric oxide in renal health and disease
  publication-title: Am. J. Kidney Dis.
  doi: 10.1016/S0272-6386(97)90275-4
– volume: 27
  start-page: 693
  year: 2009
  ident: 10.1016/j.cbi.2013.12.017_b0165
  article-title: Regulation and function of NF-kappaB transcription factors in the immune system
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev.immunol.021908.132641
– volume: 33
  issue: 829–837
  year: 2012
  ident: 10.1016/j.cbi.2013.12.017_b0015
  article-title: Nitric oxide synthases: regulation and function
  publication-title: Eur. Heart J.
– volume: 224
  start-page: 502
  year: 1995
  ident: 10.1016/j.cbi.2013.12.017_b0075
  article-title: Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite
  publication-title: Anal. Biochem.
  doi: 10.1006/abio.1995.1079
– volume: 17
  start-page: 20
  year: 2002
  ident: 10.1016/j.cbi.2013.12.017_b0140
  article-title: Chronic diabetic nephropathy: role of inducible nitric oxide synthase
  publication-title: Pediatr. Nephrol.
  doi: 10.1007/s004670200004
– volume: 20
  start-page: 1963
  year: 2009
  ident: 10.1016/j.cbi.2013.12.017_b0145
  article-title: Nitric oxide inhibits glomerular TGF-beta signaling via SMOC-1
  publication-title: J. Am. Soc. Nephrol.
  doi: 10.1681/ASN.2008060653
– volume: 18
  start-page: 93
  year: 2008
  ident: 10.1016/j.cbi.2013.12.017_b0195
  article-title: AH23848 accelerates inducible nitric oxide synthase degradation through attenuation of cAMP signaling in glomerular mesangial cells
  publication-title: Nitric Oxide
  doi: 10.1016/j.niox.2007.10.005
– volume: 35
  start-page: 313
  year: 2000
  ident: 10.1016/j.cbi.2013.12.017_b0040
  article-title: Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs
  publication-title: Am. J. Kidney Dis.
  doi: 10.1016/S0272-6386(00)70343-X
SSID ssj0000240
Score 2.134251
Snippet •LPS/IFN-γ-induced NO downregulates CTGF protein expression in MES-13 cells.•AA significantly suppressed LPS/IFN-γ-induced NO production in MES-13 cells.•AA...
Aristolochic acid (AA) is a common cause of Chinese herb nephropathy. The mechanisms involved in the pathogenesis of AA nephropathy (AAN) are intricate. One...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 86
SubjectTerms Aristolochic acid
Aristolochic Acids - pharmacology
Carcinogens - pharmacology
Cell Line
Connective tissue growth factor
Connective Tissue Growth Factor - genetics
Connective Tissue Growth Factor - metabolism
Dose-Response Relationship, Drug
Down-Regulation - drug effects
Glomerular mesangial cells
Glomerular Mesangium - cytology
Glomerular Mesangium - drug effects
Humans
Interferon Regulatory Factor-1 - metabolism
Interferon-gamma - pharmacology
Lipopolysaccharides - pharmacology
NF-kappa B - metabolism
NF-κB
Nitric oxide
Nitric Oxide - metabolism
Nitric Oxide Synthase Type II - genetics
Nitric Oxide Synthase Type II - metabolism
Signal Transduction - drug effects
STAT-1α
STAT1 Transcription Factor - metabolism
Title Downregulation of connective tissue growth factor by LPS/IFN-γ-induced nitric oxide is reversed by aristolochic acid treatment in glomerular mesangial cells via STAT-1α and NF-κB signaling
URI https://dx.doi.org/10.1016/j.cbi.2013.12.017
https://www.ncbi.nlm.nih.gov/pubmed/24412304
https://www.proquest.com/docview/1499141575
Volume 210
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF61qRBcKmh5pEA1SIgDkonXr7WPaSBKeURITaXerN31OjVqnCp2Eb3wnxA3LvyD_CZm1nYQEvTAzY9debUzntd-M8PYc0ll3aQUDleucAI_0xRo8pwoE64MOXERZSN_mEaT0-DtWXi2xUZdLgzBKlvZ38h0K63bJ4N2NweXRUE5vm7iiYQqzpEmi7fZjofaPu6xneHxu8n0t0D2ArdrqEYTusNNC_PSqiCAl2-DgrZt2V_V07_MT6uGxnfZbms_wrBZ4j22Zco9tj8s0XdeXMMLsIhOGyrfY7eOuqvbo66v2z77-Rod71XTgh6JAsscNKFdrOCD2hIC5uid1-fQdOMBdQ3vP54MjsdTZ_3dQS8e-SEDFAYoRGH5pcgMFBVQMahVhS9wuLQlC1BRnuMIqYsMNoh2KEqYXywXZkUIWFiYSpZz_AuAzhAq-FxIOJkNZw5ffwNZZjAdO-sfR0BAE0m58_fZ6fjNbDRx2jYOjvaiuHaQSXiuckXF3RL0BmOfh3kYSy2UiTwjwyDIeS5cnvlSyjh0tatDk6AwieNcKNd_wHrlsjSPGPhCoUcaeiYROoiQ5lRQL1ZayswYV_M-czvqpbqtcU6tNi7SDsz2KUWCp0TwlHspErzPXm6mXDYFPm4aHHQskf7BpSkqoJumPevYJ0Vi03bK0iyvKnS80D5HG0qEffaw4avNKtDw4hSyP_i_jz5md_AusHi58Anr1asr8xQNqFodsu1XX_lh-5v8AvEgHDc
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKESoXBC2U5TlIiAOS2TiJ8zhuF1Zb2K6QupV6ixzH2QZ1k2qzRfTCf0LcuPAP9jcx4ySLkKAHblFsK5FnPA_78zeMvVRE66ZUyEXqhNz3Mk0bTS4PstBRUpAW0W3ko2kwPvHfn8rTLTbs7sIQrLK1_Y1Nt9a6fdNvZ7N_URR0x9eJ3TAmxjnyZNENdtOnMgeo1G--_sZ5EIlXV06NundHmxbkpdOC4F2e3RK0Rcv-6pz-FXxaJzS6y-600SMMmh-8x7ZMucv2BiVmzosreAUWz2k3ynfZrYPuaWfYVXXbYz_fYtq9bArQo0igykET1sWaPVhZMcAcc_PVGTS1eCC9gsnH4_7haMrX3znm8KgNGaApQBMK1ZciM1DUQFRQyxobsLuyhAXoJs-wh9JFBhs8OxQlzM-rhVkS_hUWplblHNcA0AlCDZ8LBcezwYyL9TdQZQbTEV__OACCmSi6OX-fnYzezYZj3hZx4NoNohVHFRF5mqdE7RZjLhh5QuYyUjpMTeAaJX0_F3noiMxTSkXS0Y6WJkZTEkV5mDreA7ZdVqV5yMALU8xHpWviUPsBSpzo9KJUK5UZ42jRY04nvUS3DOdUaOM86aBsnxIUeEICT4SboMB77PVmyEVD73FdZ79TieQPHU3Q_Vw37EWnPgkKm6ZTlaa6rDHtwugcI6hQ9th-o1ebv8CwS9CG_aP_--hztjOeHU2SyeH0w2N2G1t8i5yTT9j2anlpnmIotUqf2aXyC0WWHPk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Downregulation+of+connective+tissue+growth+factor+by+LPS%2FIFN-%CE%B3-induced+nitric+oxide+is+reversed+by+aristolochic+acid+treatment+in+glomerular+mesangial+cells+via+STAT-1%CE%B1+and+NF-%CE%BAB+signaling&rft.jtitle=Chemico-biological+interactions&rft.au=Tsai%2C+Kuen-Daw&rft.au=Chen%2C+Wei&rft.au=Wang%2C+Sue-Hong&rft.au=Hsiao%2C+Yu-Wei&rft.date=2014-03-05&rft.issn=1872-7786&rft.eissn=1872-7786&rft.volume=210&rft.spage=86&rft_id=info:doi/10.1016%2Fj.cbi.2013.12.017&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-2797&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-2797&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-2797&client=summon